Literature DB >> 28655929

Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity.

Yoshiaki Takahashi1, Eijiro Umemura1, Yoshihiko Kobayashi1, Shoichi Murakami2, Toru Nawa2, Akihiro Morinaka2, Toshiaki Miyake1, Masakatsu Shibasaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28655929     DOI： 10.1038/ja.2017.60

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  11 in total

1.  Clinical, economic and societal impact of antibiotic resistance.

Authors:  Steven L Barriere
Journal:  Expert Opin Pharmacother       Date:  2014-12-06       Impact factor: 3.889

2.  Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance.

Authors:  Laura J V Piddock
Journal:  Lancet Infect Dis       Date:  2016-05-18       Impact factor: 25.071

3.  Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.

Authors:  Reiko Sato; Yusuke Tanigawara; Mitsuo Kaku; Naoki Aikawa; Kihachiro Shimizu
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

4.  Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.

Authors:  S Kondo; K Iinuma; H Yamamoto; K Maeda; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1973-07       Impact factor: 2.649

5.  Mutational biosynthesis by idiotrophs of Micromonospora purpurea. I. Conversion of aminocyclitols to new aminoglycoside antibiotics.

Authors:  D Rosi; W A Goss; S J Daum
Journal:  J Antibiot (Tokyo)       Date:  1977-01       Impact factor: 2.649

6.  Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.

Authors:  M Inoue; M Nonoyama; R Okamoto; T Ida
Journal:  Drugs Exp Clin Res       Date:  1994

7.  Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates.

Authors:  Karen Smith; Iain S Hunter
Journal:  J Med Microbiol       Date:  2008-08       Impact factor: 2.472

8.  Study on fluorination-toxicity relationships. Syntheses of 1-N-[(2R,3R)- and (2R,3S)-4-amino-3-fluoro-2-hydroxybutanoyl] derivatives of kanamycins.

Authors:  Y Takahashi; C Ueda; T Tsuchiya; Y Kobayashi
Journal:  Carbohydr Res       Date:  1993-10-18       Impact factor: 2.104

9.  Synthesis of 1-N-[(2S,4S)- and (2S,4R)-5-amino-4-fluoro-2-hydroxypentanoyl]dibekacins (study on structure-toxicity relationships).

Authors:  Y Takahashi; J Kohno; T Tsuchiya
Journal:  Carbohydr Res       Date:  1998-01       Impact factor: 2.104

Review 10.  Clinical Usefulness of Arbekacin.

Authors:  Jae Hoon Lee; Chang-Seop Lee
Journal:  Infect Chemother       Date:  2016-03-31
View more
  1 in total

Review 1.  Destination of aminoglycoside antibiotics in the 'post-antibiotic era'.

Authors:  Yoshiaki Takahashi; Masayuki Igarashi
Journal:  J Antibiot (Tokyo)       Date:  2017-10-25       Impact factor: 2.649
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.